In this study, we identify IER5L as a gene that is upregulated in different cancer types, including PCa, and that IER5L upregulation contributes to the maintenance of metastatic properties of PCa tumor cells in vitro and in vivo. This evidence concerns the gene IER5L and neoplasm.